Elequin Capital’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-45,072
Closed -$613K – 173
2025
Q2
$613K Buy
45,072
+37,993
+537% +$543K 0.08% 87
2025
Q1
$105K Buy
7,079
+1,214
+21% +$19K 0.01% 129
2024
Q4
$84.5K Buy
+5,865
New +$90.8K 0.01% 121
2024
Q1
– Sell
-17,776
Closed -$260K – 271
2023
Q4
$260K Buy
+17,776
New +$248K 0.08% 95
2023
Q2
– Sell
-4,500
Closed -$75.2K – 549
2023
Q1
$75.2K Sell
4,500
-89,510
-95% -$1.44M 0.05% 94
2022
Q4
$1.45M Buy
+94,010
New +$1.46M 0.41% 30

Other funds holding BMEZ

Elequin Capital's BMEZ Position: Q3 2025 in Review

Elequin Capital sold out of BlackRock Health Sciences Trust II (BMEZ) in Q3 2025, closing a stake of 45,072 shares — an estimated $613K sold.

Elequin Capital first reported a position in BMEZ in Q4 2022 and held it in 6 quarters. The position peaked at $1.45M in Q4 2022. 79 funds tracked by Wall St. Rank hold BMEZ as of Q3 2025.

  • Elequin Capital reported no remaining BlackRock Health Sciences Trust II position as of Q3 2025 after selling out during the quarter.
  • Elequin Capital sold 45,072 BlackRock Health Sciences Trust II shares in Q3 2025, an estimated $613K.
  • Elequin Capital first reported a position in BlackRock Health Sciences Trust II in Q4 2022 and held it in 6 quarters.
  • Elequin Capital's BlackRock Health Sciences Trust II position peaked at $1.45M in Q4 2022.
  • 79 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q3 2025.

Based on Elequin Capital's 13F filing for Q3 2025, filed 14 Nov 2025.